Search results
Better Buy: Inovio Pharmaceuticals vs. Novavax
Motley Fool via Yahoo Finance· 6 days agoThe COVID-19 vaccine was worth tens of billions of dollars, but most of it went into the hands of Moderna and Pfizer. Smaller biotechs that tried to...
Better Buy: Inovio Pharmaceuticals vs. Novavax | The Motley Fool
The Motley Fool· 6 days agoThe COVID-19 vaccine was worth tens of billions of dollars, but most of it went into the hands of...
Arbutus, Novavax See Activist Investor Action
Barrons.com· 4 days agoShah had filed a May 6 proxy statement calling for shareholders to vote against the re-election of three directors. In the recent 13D amendment, filed on...
Novavax awaits FDA decision on whether its next COVID shot can be offered in US
AOL· 4 days agoNovavax's updated vaccine targets a variant called JN.1, which is in line with European recommendations. The European Union's regulator told vaccine makers last month to update ...
Novavax Sees Unusually Large Options Volume (NASDAQ:NVAX)
ETF DAILY NEWS· 6 days agoNovavax, Inc. (NASDAQ:NVAX – Get Free Report) was the target of some unusual options trading activity on Wednesday. Novavax has a 1 year low of $3.53 and ...
The FLiRT COVID variants: What are they and are they more contagious?
Reuters· 4 days agoThe moniker FLiRT is an acronym for the locations of the mutations the variants share on the virus'...
Novavax awaits FDA decision on whether its next COVID shot can be offered in US
Reuters· 4 days ago, opens new tab will only be able to offer a COVID-19 vaccine in the United States this autumn if regulators accept the shot it has started manufacturing that targets a variant that was dominant ...
Novavax Unusual Options Activity For May 23 - Novavax (NASDAQ:NVAX)
Benzinga· 5 days agoLoading... Loading... Deep-pocketed investors have adopted a bearish approach towards Novavax NVAX , and it's something market players shouldn't ignore. Our tracking of public ...
Researchers are developing an experimental bird flu mRNA vaccine
Quartz· 9 hours agoResearchers are developing an mRNA-based vaccine against the contagious H5N1 bird flu virus that is...
Why Vaccine Stocks Rallied This Week
The Motley Fool via AOL· 5 days agoShares of vaccine stocks Moderna (NASDAQ: MRNA), Novavax (NASDAQ: NVAX), and BioNTech SE (NASDAQ: BNTX) rallied this week, appreciating 23.4%, 16.4%, and...
